Clinic
Laredo Texas Hospital Company LP
Laredo Texas Hospital Company LP was paid $19.46M by Medicaid between Nov 2018 and Dec 2024, across 221 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.
33Billing provider infoLAREDO TEXAS HOSPITAL COMPANY LP
LAREDO, TX 78041
LAREDO, TX 78041
33aNPI1548232044assigned 02/07/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$19.46M
24GClaims523,147
24DCodes billed221
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#24 of 320
Median peer was paid$205K
This provider vs. median95×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15 | $156.28 | |
| 2019 | 905 | $21K | |
| 2020 | 10,496 | $376K | |
| 2021 | 113,502 | $3.01M | |
| 2022 | 163,340 | $6.10M | |
| 2023 | 149,498 | $6.70M | |
| 2024incomplete | 85,391 | $3.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 20,901 | 19,962 | $6.68M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 6,209 | 5,812 | $2.29M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.9% | 28,320 | 27,450 | $1.35M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 2,131 | 2,069 | $819K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.4% | 11,335 | 11,164 | $655K |
| 71046 | Radiologic examination, chest; 2 views | 2.9% | 10,478 | 10,284 | $564K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 11,641 | 11,205 | $522K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 23,919 | 23,074 | $507K |
| G0378 | Hospital observation service, per hour | 2.3% | 2,631 | 2,247 | $457K |
| 80053 | Comprehensive metabolic panel | 2.2% | 39,376 | 36,667 | $423K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 52,149 | 47,361 | $422K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 10,041 | 7,123 | $409K |
209 more codes
| 80050 | General health panel | 1.6% | 1,848 | $306K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 2,864 | $301K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 7,234 | $209K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,133 | $177K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,367 | $170K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,179 | $162K |
| 80061 | Lipid panel | <1% | 13,354 | $161K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 10,098 | $131K |
| 99218 | <1% | 618 | $121K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,428 | $119K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,271 | $113K |
| 81001 | <1% | 31,120 | $113K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,143 | $113K |
| 87807 | <1% | 4,407 | $111K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 947 | $102K |
| 83525 | <1% | 4,882 | $87K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,680 | $85K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,449 | $81K |
| 87430 | <1% | 2,437 | $79K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 652 | $63K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 966 | $62K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,877 | $62K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,419 | $62K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,861 | $56K |
| 74018 | <1% | 1,216 | $56K | |
| 83655 | <1% | 2,610 | $54K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 512 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 776 | $41K |
| CP007 | <1% | 707 | $38K | |
| 84702 | <1% | 2,032 | $36K | |
| 84481 | <1% | 1,313 | $34K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 402 | $32K |
| 84436 | <1% | 3,011 | $31K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,375 | $30K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,370 | $30K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 198 | $29K |
| 84439 | <1% | 3,954 | $28K | |
| 83690 | <1% | 3,681 | $27K | |
| 71250 | <1% | 490 | $27K | |
| 84703 | <1% | 2,330 | $25K | |
| 82248 | <1% | 3,679 | $24K | |
| 87040 | <1% | 2,263 | $24K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 422 | $22K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,413 | $21K |
| 82977 | <1% | 1,763 | $21K | |
| 83880 | <1% | 1,804 | $20K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,685 | $20K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 617 | $19K |
| 84484 | <1% | 3,658 | $19K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 525 | $17K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,192 | $17K |
| 87428 | <1% | 432 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,509 | $16K |
| 84460 | <1% | 1,775 | $15K | |
| 84450 | <1% | 1,708 | $14K | |
| 72081 | <1% | 177 | $14K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 622 | $14K |
| 73562 | <1% | 518 | $13K | |
| 95816 | <1% | 34 | $13K | |
| 86003 | <1% | 117 | $13K | |
| 86850 | <1% | 1,075 | $12K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 139 | $12K |
| 82077 | <1% | 717 | $11K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 88 | $11K |
| 76641 | <1% | 121 | $10K | |
| 76775 | <1% | 275 | $9K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 235 | $9K |
| 87186 | <1% | 2,639 | $9K | |
| 85610 | <1% | 3,959 | $9K | |
| 74246 | <1% | 53 | $9K | |
| 87077 | <1% | 2,671 | $9K | |
| 83605 | <1% | 1,234 | $8K | |
| 85730 | <1% | 2,693 | $8K | |
| 82607 | <1% | 2,235 | $8K | |
| 82728 | <1% | 1,429 | $8K | |
| 73030 | <1% | 318 | $7K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 8,444 | $7K |
| 83498 | <1% | 159 | $6K | |
| 73630 | <1% | 203 | $6K | |
| 76536 | <1% | 52 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 437 | $6K |
| 83970 | <1% | 805 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 154 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 154 | $6K |
| 70260 | <1% | 66 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,348 | $6K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 3,685 | $5K |
| 83789 | <1% | 159 | $5K | |
| 72100 | <1% | 186 | $5K | |
| 77080 | <1% | 1,097 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 42 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 189 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,311 | $4K |
| 86900 | <1% | 2,095 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,805 | $4K |
| 86901 | <1% | 2,094 | $4K | |
| 82746 | <1% | 1,156 | $4K | |
| 81025 | <1% | 411 | $4K | |
| 83735 | <1% | 1,728 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 345 | $4K |
| 82261 | <1% | 159 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 48 | $4K |
| 84466 | <1% | 911 | $4K | |
| 80179 | <1% | 239 | $4K | |
| 83520 | <1% | 159 | $4K | |
| 80143 | <1% | 227 | $4K | |
| 83540 | <1% | 1,433 | $4K | |
| 96415 | <1% | 56 | $4K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 145 | $3K |
| 85027 | <1% | 314 | $3K | |
| 83020 | <1% | 159 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,170 | $3K |
| 83630 | <1% | 77 | $3K | |
| 85379 | <1% | 501 | $3K | |
| 82570 | <1% | 2,861 | $3K | |
| 82550 | <1% | 866 | $3K | |
| 82776 | <1% | 159 | $3K | |
| 87340 | <1% | 419 | $3K | |
| 74022 | <1% | 13 | $2K | |
| 82652 | <1% | 55 | $2K | |
| 80069 | <1% | 1,604 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $2K |
| 86140 | <1% | 590 | $2K | |
| 82043 | <1% | 2,127 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,051 | $2K |
| 87425 | <1% | 80 | $2K | |
| 82150 | <1% | 362 | $2K | |
| 85007 | <1% | 309 | $2K | |
| 82247 | <1% | 271 | $2K | |
| 86592 | <1% | 542 | $2K | |
| 88304 | <1% | 73 | $2K | |
| 80047 | <1% | 196 | $2K | |
| 80074 | <1% | 67 | $2K | |
| 84437 | <1% | 159 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 103 | $2K |
| 84153 | <1% | 752 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,296 | $1K |
| 87045 | <1% | 80 | $1K | |
| 96417 | <1% | 15 | $1K | |
| 73610 | <1% | 44 | $1K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 24 | $1K |
| 82105 | <1% | 182 | $1K | |
| 87209 | <1% | 40 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,786 | $1K |
| 70360 | <1% | 14 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,412 | $1K |
| 82785 | <1% | 48 | $1K | |
| 85652 | <1% | 912 | $1K | |
| 73130 | <1% | 26 | $1K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 227 | $1K |
| 73560 | <1% | 70 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,395 | $1K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 25 | $970.35 |
| 82565 | <1% | 492 | $914.83 | |
| 73502 | <1% | 39 | $895.74 | |
| 84100 | <1% | 787 | $879.30 | |
| 82272 | <1% | 212 | $862.37 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,646 | $839.66 |
| 87070 | <1% | 308 | $824.39 | |
| 86038 | <1% | 92 | $816.28 | |
| 84550 | <1% | 740 | $782.03 | |
| 82140 | <1% | 153 | $771.96 | |
| 80076 | <1% | 88 | $770.28 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 13 | $641.60 |
| 87177 | <1% | 40 | $632.74 | |
| 86920 | <1% | 43 | $631.64 | |
| 86803 | <1% | 26 | $592.16 | |
| 84156 | <1% | 756 | $556.97 | |
| 84520 | <1% | 430 | $505.48 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 106 | $401.53 |
| 82378 | <1% | 72 | $336.20 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,215 | $332.73 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 15 | $257.73 |
| 83986 | <1% | 38 | $237.16 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 110 | $210.79 |
| 72110 | <1% | 12 | $195.45 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 611 | $165.76 |
| 82947 | <1% | 27 | $157.50 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $131.72 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 175 | $129.91 |
| 85018 | <1% | 144 | $123.51 | |
| 84145 | <1% | 13 | $114.30 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 15 | $87.57 |
| 83615 | <1% | 41 | $86.91 | |
| 90715 | <1% | 12 | $84.58 | |
| 86430 | <1% | 14 | $77.40 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 19 | $68.76 |
| 81003 | <1% | 33 | $67.05 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,468 | $59.61 |
| 85045 | <1% | 24 | $50.66 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 211 | $46.94 |
| 86334 | <1% | 12 | $37.54 | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 32 | $34.40 |
| 94760 | <1% | 36 | $29.12 | |
| 94664 | <1% | 25 | $18.99 | |
| 84165 | <1% | 12 | $18.04 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 16 | $16.92 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,685 | $15.59 |
| 87075 | <1% | 16 | $13.44 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 12 | $10.54 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 28 | $8.16 |
| 82962 | <1% | 5,390 | $6.92 | |
| 84155 | <1% | 12 | $6.16 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 30 | $0.00 |
| 99152 | 0% | 12 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 18 | $0.00 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 1,407 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 12 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.